BACKGROUND: Evaluation of health-related quality of life (HRQOL) in cervical cancer patients is important in order to design the interventions for improving patient outcomes. Reports of HRQOL among cervical cancer patients in Indonesia are limited. Moreover, measurement using EQ-5D-3L is to our best knowledge has hitherto not been performed. This study aimed to examine the HRQOL of cervical cancer patients in Indonesia using EQ- 5D-3L. MATERIALS AND METHODS: A cross-sectional study was conducted by interviewing cervical cancer patients using the EQ-5D-3L questionnaire. Percentages of patients who reported having problems in each dimension of EQ-5D as well as EQ-5D index score (utility) were calculated. RESULTS: Our findings indicated that the most frequent reported problems were pain/discomfort (67.8%) followed by anxiety/depression (57.5%). The mean of EQ-5D VAS was 75.8 (SD=17.0). The mean (SD) utility scores were 0.85 (0.19), 0.76 (0.20), 0.71 (0.21), and 0.77 (0.13) for cervical cancer patients in stage I, II, III, and IV, respectively. CONCLUSIONS: Cervical cancer significantly affects patient HRQOL. Efforts should be made to improve the quality of life of cervical cancer patients especially in terms of pain /discomfort and anxiety/depression reduction.
BACKGROUND: Evaluation of health-related quality of life (HRQOL) in cervical cancerpatients is important in order to design the interventions for improving patient outcomes. Reports of HRQOL among cervical cancerpatients in Indonesia are limited. Moreover, measurement using EQ-5D-3L is to our best knowledge has hitherto not been performed. This study aimed to examine the HRQOL of cervical cancerpatients in Indonesia using EQ- 5D-3L. MATERIALS AND METHODS: A cross-sectional study was conducted by interviewing cervical cancerpatients using the EQ-5D-3L questionnaire. Percentages of patients who reported having problems in each dimension of EQ-5D as well as EQ-5D index score (utility) were calculated. RESULTS: Our findings indicated that the most frequent reported problems were pain/discomfort (67.8%) followed by anxiety/depression (57.5%). The mean of EQ-5D VAS was 75.8 (SD=17.0). The mean (SD) utility scores were 0.85 (0.19), 0.76 (0.20), 0.71 (0.21), and 0.77 (0.13) for cervical cancerpatients in stage I, II, III, and IV, respectively. CONCLUSIONS:Cervical cancer significantly affects patient HRQOL. Efforts should be made to improve the quality of life of cervical cancerpatients especially in terms of pain /discomfort and anxiety/depression reduction.
Authors: Fredrick Dermawan Purba; Joke A M Hunfeld; Aulia Iskandarsyah; Titi Sahidah Fitriana; Sawitri Supardi Sadarjoen; Juan Manuel Ramos-Goñi; Jan Passchier; Jan J V Busschbach Journal: Pharmacoeconomics Date: 2017-11 Impact factor: 4.981
Authors: Julia Schröders; Stig Wall; Mohammad Hakimi; Fatwa Sari Tetra Dewi; Lars Weinehall; Mark Nichter; Maria Nilsson; Hari Kusnanto; Ekowati Rahajeng; Nawi Ng Journal: PLoS One Date: 2017-06-20 Impact factor: 3.240
Authors: Bustanul Arifin; Fredrick Dermawan Purba; Hendra Herman; John M F Adam; Jarir Atthobari; Catharina C M Schuiling-Veninga; Paul F M Krabbe; Maarten J Postma Journal: Health Qual Life Outcomes Date: 2020-02-07 Impact factor: 3.186
Authors: Fredrick Dermawan Purba; Joke A M Hunfeld; Aulia Iskandarsyah; Titi Sahidah Fitriana; Sawitri S Sadarjoen; Jan Passchier; Jan J V Busschbach Journal: PLoS One Date: 2018-05-11 Impact factor: 3.240